在PfCyRPA上有一个可向的受体结合部位,以帮助对抗疟疾
Thayne H Dickey1, Niraj H Tolia1
1Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20894, USA.
Trends in parasitology
|April 11, 2024
概括
研究人员发现疟疾寄生虫蛋白PfCyRPA的结合部位与宿主糖Neu5Ac相互作用. 阻止这种相互作用阻碍了寄生虫的生长,为抗疟疾疫苗和药物提供了一个新的目标.
科学领域:
- 疟疾学 疟疾学
- 寄生虫学的寄生虫学
- 结构生物学 结构生物学
背景情况:
- 疟疾仍然是一个重大的全球卫生挑战,需要新的治疗和疫苗策略.
- 了解宿主-寄生虫相互作用对于开发针对Plasmodium falciparum的有效干预措施至关重要.
研究的目的:
- 识别和描述疟疾寄生虫蛋白PfCyRPA上的受体结合部位.
- 研究宿主糖N-乙神经胺酸 (Neu5Ac) 在疟疾寄生虫入侵和生长中的作用.
主要方法:
- 对PfCyRPA蛋白质进行结构分析,以绘制其受体结合部位.
- 生物化学测定证实了Neu5Ac与PfCyRPA的结合.
- 对寄生虫进行基因操纵,以破坏PfCyRPA-Neu5Ac相互作用,并评估其对寄生虫生长的影响.
主要成果:
- 在PfCyRPA上确定了一个特定的受体结合部位.
- 发现pfCyRPA可以结合宿主糖Neu5Ac.
- 破坏PfCyRPA-Neu5Ac相互作用显著阻碍了疟疾寄生虫的生长.
结论:
- 该PfCyRPA-Neu5Ac相互作用对于疟疾寄生虫生存能力至关重要.
- 鉴定的受体结合部位是开发新型抗疟疾疫苗和治疗方法的有希望的目标.
更多相关视频
10:38High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
23.1K
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.4K
相关概念视频
Targets for Drug Action: Overview
9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
